Mango Rx CEO Discusses Men's Telehealth Initiatives on Benzinga's All-Access
Mango Rx CEO Discusses Men's Telehealth Initiatives on Benzinga's All-Access
Mango Rx CEO Discusses Men's Telehealth Initiatives on Benzinga's All-Access
Key Takeaways (TLDR)
Invest in Mango Rx (NASDAQ: MGRX) for potential growth in the men's wellness telemedicine sector.
Mango Rx focuses on men's health and wellness products via secure telemedicine, including erectile dysfunction, hair growth, and hormone replacement therapies.
Mango Rx's telemedicine products and services aim to improve men's health and wellness, making tomorrow better than today.
Mango Rx CEO, Jacob Cohen, discusses the company's focus on men's health and wellness products and services on Benzinga’s All-Access.
Why it Matters
This news matters as it sheds light on a unique approach to men's telehealth and wellness products, addressing important issues such as erectile dysfunction and hormone replacement therapies.
Summary
Jacob Cohen, CEO of Mango Rx (NASDAQ: MGRX), was recently a guest on Benzinga’s All-Access. Mangoceuticals is focused on developing men's health and wellness products and services via a secure telemedicine platform, with a particular focus on erectile dysfunction, hair growth, and hormone replacement therapies.
This news story relied on a press release distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Mango Rx CEO Discusses Men's Telehealth Initiatives on Benzinga's All-Access.